Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma

Osteosarcoma (OS) is a bone cancer mostly occurring in pediatric population. Current treatment regime of surgery and intensive chemotherapy could cure about 60%–75% patients with primary osteosarcoma, however only 15% to 30% can be cured when pulmonary metastasis or relapse has taken place. Hence, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaikh, Atik Badshah, Li, Fangfei, Li, Min, He, Bing, He, Xiaojuan, Chen, Guofen, Guo, Baosheng, Li, Defang, Jiang, Feng, Dang, Lei, Zheng, Shaowei, Liang, Chao, Liu, Jin, Lu, Cheng, Liu, Biao, Lu, Jun, Wang, Luyao, Lu, Aiping, Zhang, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848962/
https://www.ncbi.nlm.nih.gov/pubmed/27058531
http://dx.doi.org/10.3390/ijms17040506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848962/
https://www.ncbi.nlm.nih.gov/pubmed/27058531
http://dx.doi.org/10.3390/ijms17040506

Ejemplares similares